Standard breakfast test: an alternative to glucagon testing for C-peptide reserve?

Area of Science:

• Endocrinology
• Metabolic Disorders
• Diabetes Research

Background:

• Assessing residual beta cell function is crucial for diabetes management.
• Glucagon and breakfast tests are used to evaluate pancreatic islet cell activity.
• Comparing the efficacy of different stimulation tests is important for clinical practice.

Purpose of the Study:

• To compare the effectiveness of glucagon and standard breakfast tests.
• To evaluate residual beta cell function in various subject groups.
• To determine the utility of the breakfast test for C-peptide measurement.

Main Methods:

• C-peptide levels were measured following both glucagon and standard breakfast stimulation.
• Subjects included normal individuals and patients with insulin-dependent diabetes mellitus (IDDM) and noninsulin-dependent diabetes mellitus (NIDDM).
• Data were analyzed to compare responses between the two tests and across different subject cohorts.

Main Results:

• The standard breakfast test elicited a significantly higher C-peptide response in patients with recent-onset IDDM (P < 0.05).
• Significant C-peptide responses were observed in nonobese NIDDM (P < 0.0025), obese NIDDM (P < 0.05), and normal subjects (P < 0.0025) after breakfast.
• The breakfast test demonstrated a practical and useful method for assessing beta cell function.

Conclusions:

• The standard breakfast test is a valuable tool for studying residual beta cell function.
• This test provides a practical and effective method for C-peptide assessment in clinical settings.
• The breakfast test shows comparable or superior utility to glucagon stimulation for evaluating beta cell reserve.